This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The number of patients living with obesity keeps growing, and following the recent advances in the therapeutic space, more patients are being prescribed pharmacotherapy on top of the usual diet and exercise lifestyle changes, which by themselves are often unsuccessful. With physicians and patients awareness expected to increase, sales of obesity medications are forecast to reach $173.5 billion in the seven major markets (7MM*) by 2031, according to GlobalData.
In this episode, I’ll discuss the impact of compounded oral vancomycin liquid on hospital readmission for C diff infection. Episode 1001: Saving Money on Oral Vancomycin Is Great For Inpatients But Can Cause Problems On Discharge Subscribe on iTunes , Android , or Stitcher The drug acquisition cost for oral vancomycin capsules is several orders of magnitude larger than for liquid vancomycin prepared from the IV formulation and given via the oral route.
Amlenetug could provide a treatment option for patients with multiple system atrophy, a progressive and rare condition that causes damage to the brains nerve cells.
The path from the atrocities of Nuremberg and Tuskegee to today’s robust ethics of medical research has not been easy. In response to these horrific events, a remarkable global consensus emerged, across countries in very different parts of the world and with very different types of governments: Medical researchers, and the institutions and companies who fund their work, are bound by a series of ethical obligations.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
DLL3 is an emerging therapeutic target in small cell lung cancer and other neuroendocrine carcinomas, with 1 FDA-approved therapy and several others under investigation.
The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, pharmaceutical companies are looking for innovative ways to stay ahead of the competition. One strategy that's gaining traction is biosimilar-to-biosimilar switching. But what does this mean, and how can you make it work for your business? Biosimilar-to-biosimilar switching involves switching patients from one biosimilar to another, often to improve efficacy, reduce costs, or enhance patient o
The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, pharmaceutical companies are looking for innovative ways to stay ahead of the competition. One strategy that's gaining traction is biosimilar-to-biosimilar switching. But what does this mean, and how can you make it work for your business? Biosimilar-to-biosimilar switching involves switching patients from one biosimilar to another, often to improve efficacy, reduce costs, or enhance patient o
In this article insights are provided about the new book “Learn Antibiotics: Book of Games” which is available for purchase today on most Amazon marketplaces around the globe. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Posted17 February 2024 The book Learn Antibiotics: Book of Games was released for sale on Amazon in late 2024.
It can be overwhelming walking into the pharmacy and looking down the vitamin aisle especially when you finally find a specific supplement, only to discover there are numerous forms lining the shelves. This gets even more challenging when you dont know which salt form will be the most beneficial for your specific needs.We wanted […] The post Comparison of Magnesium Supplements – Which One To Choose?
Sweeping layoffs are set to hit federal health and science agencies , including at the National Institutes of Health, and former director Monica Bertagnolli called the situation at the NIH “devastating.” “We’re going to lose the next generation, that is the most difficult loss. This just sends, sends a chill,” Bertagnolli told STAT in an interview Saturday on the sidelines of the American Association for the Advancement of Science annual meeting in Boston.
WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to have hit the AI and digital health staff particularly hard at a time when federal regulators are scrambling for ways to keep tabs on hospitals and insurers that are embracing the technologies. The terminations, with their potential to halt or hobble AI regulation, have caused alarm both inside and outside the agency, according to people interviewed by STAT.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
105 
Let's personalize your content